DCF Advises Another Radiation Oncology Services Provider

Radiation Oncology Associates Partners with Oncure Medical Corp.

Deloitte Corporate Finance

Deloitte Corporate Finance LLC (DCF) is pleased to announce its role as the exclusive financial advisor to Radiation Oncology Associates, P.C. and ROA Associates, LLP (ROA) on its partnership arrangement with Oncure Medical Corporation (Oncure). As part of the partnership arrangement, ROA has entered into a transaction which includes remuneration for certain technical assets and a long-term management services agreement with Oncure. The partnership represents the second transaction in the radiation oncology sector in which DCF acted as exclusive financial advisor in the transaction.

About ROA and Oncure
Established nearly 30 years ago, ROA is one of the largest providers of comprehensive cancer radiation treatment and consultative services in Northeast Indiana and adjacent border communities. ROA possesses a noteworthy depth of highly trained and experienced physician specialists, fully collaborating to enable provision of full spectrum radiation oncology related patient access to state-of-the-art technology with a committed focus to compassionate and quality individualized care. ROA sites include departments at the two largest Ft. Wayne hospital systems, as well as satellite offices at regional, smaller community hospitals.

Oncure is one of the largest providers of outpatient radiation oncology care in the US. Oncure partners with radiation oncologists to support leading edge cancer care at its treatment centers, and provides its physicians and hospital partners with capital, management and clinical expertise, billing services, information technology, human resource management, compliance services, accounting and payor contracting services.